Penserra Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-510	Closed	-$26K	–	1458
2021 Q3	$26K	Buy	510 +5	+1%	+$255	﹤0.01%	1209
2021 Q2	$34K	Buy	505 +5	+1%	+$337	﹤0.01%	1077
2021 Q1	$38K	Buy	500 +50	+11%	+$3.8K	﹤0.01%	861
2020 Q4	$27K	Buy	+450	New	+$27K	﹤0.01%	808